Results 251 to 260 of about 31,156,887 (403)

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

Journal of Clinical Oncology, 2016
Jennifer N. Brudno, R. Somerville, V. Shi, J. Rose, David C. Halverson, D. Fowler, J. Gea-Banacloche, S. Pavletic, D. Hickstein, Tangying Lu, S. Feldman, A. Iwamoto, R. Kurlander, I. Maric, A. Goy, B. Hansen, Jennifer S. Wilder, Bazetta Blacklock-Schuver, F. Hakim, S. Rosenberg, R. Gress, J. Kochenderfer   +21 more
semanticscholar   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

The Cytopathic Effects of HGP Virus and Coxsackievirus B Type 5 on HEp2 Cells

, 1967
Christopher Keck, Melvin S. Rosenthal
openalex   +1 more source

Antigen-induced co-capping of IgM and IgD-like receptors on murine B cells. [PDF]

, 1976
James W. Goding, Judith E. Layton
openalex   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

B-Cell Lymphoma Presenting as a Pancreatic Mass. [PDF]

J Med Cases
Badran S, Phan AT, Kanan A, Nguyen VT, Bourbeau-Medinilla K.   +4 more
europepmc   +1 more source

Control of Human B Lymphocyte Responsiveness: Enhanced Suppressor T Cell Activity after in vitro Incubation [PDF]

, 1978
Peter E. Lipsky, William W. Ginsburg, Fred D. Finkelman, Morris Ziff   +3 more
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies. [PDF]

Compr Physiol
Kasibante J, Brown TT, Lake JE, Abdel-Mohsen M.   +3 more
europepmc   +1 more source

Vacuolization in Cultured Cells Induced by Amphotericin B [PDF]

, 1978
Erik Lundgren, Göran Roos
openalex   +1 more source